Phospholamban mediates the b-adrenergic-enhanced Ca2+ uptake in mammalian ventricular myocytes: J.S.K. Sham, et al.; Am. J. Physiol. 261, H1344 (1991) Abstract Phospholamban expressed in slow-twitch and chronically stimulated fast-twitch muscles minimally affects calcium affinity of sarcoplasmic reticulum Ca(2+)-ATPase: F.N. Briggs, et al.; J. Biol. Chem. 267, 26056 (1992) Abstract; Full Text Residues 2-25 of phospholamban are insufficient to inhibit Ca2+ transport ATPase of cardiac sarcoplasmic reticulum: L.R. Jones and L.J. Field; J. Biol. Chem. 268, 11486 (1993) Abstract; Full Text Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases. Effect of a phospholamban antibody on enzyme activation by Ca2+: T. Cantilina, et al.; J. Biol. Chem. 268, 17018 (1993) Abstract; Full Text The Ca2+-release channel/ryanodine receptor is localized in junctional and corbular sarcoplasmic reticulum in cardiac muscle: A.O. Jorgensen, et al.; J. Cell Biol. 120, 969 (1993) Abstract; Full Text Molecular and physiological alterations in murine ventricular dysfunction: H.A. Rockman, et al.; PNAS 91, 2694 (1994) Abstract; Full Text Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies: B. O’Rourke, et al.; Circ. Res. 84, 562 (1999) Abstract; Full Text Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy: S.U. Trost, et al.; Diabetes 51, 1166 (2002) Abstract; Full Text Ca(2+) signaling in cardiac myocytes overexpressing the alpha(1) subunit of L-type Ca(2+) channel: L.S. Song, et al.; Circ. Res. 90, 174 (2002) Abstract; Full Text Abnormal Ca2+ release, but normal ryanodine receptors, in canine and human heart failure: M.T. Jiang, et al.; Circ. Res. 91, 1015 (2002) Abstract; Full Text Targeting phospholamban by gene transfer in human heart failure: F. del Monte, et al.; Circulation 105, 904 (2002) Abstract; Full Text Type 1 phosphatase, a negative regulator of cardiac function: A.N. Carr, et al.; Mol. Cell. Biol. 22, 4124 (2002) Abstract; Full Text Altered dose response to beta-agonists in SERCA1a-expressing hearts ex vivo and in vivo: S. Huke, et al.; Am. J. Physiol. Heart Circ. Physiol. 283, H958 (2002) Abstract; Full Text Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats: K.M. Choi, et al.; Am. J. Physiol. Heart Circ. Physiol. 283, H1398 (2002) Abstract; Full Text Interaction between increased SERCA2a activity and beta -adrenoceptor stimulation in adult rabbit myocytes: B. Chaudhri, et al.; Am. J. Physiol. Heart Circ. Physiol. 283, H2450 (2002) Abstract; Full Text Targeted inhibition of Ca2+/calmodulin-dependent protein kinase II in cardiac longitudinal sarcoplasmic reticulum results in decreased phospholamban phosphorylation at threonine 17: Y. Ji, et al.; J. Biol. Chem. 278, 25063 (2003) Abstract; Full Text Nitric oxide protects cardiac sarcolemmal membrane enzyme function and ion active transport against ischemia-induced inactivation: K.Y. Xu, et al.; J. Biol. Chem. 278, 41798 (2003) Abstract; Full Text Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt: Y.K. Kim, et al.; J. Biol. Chem. 278, 47622 (2003) Abstract; Full Text Regional alterations in protein expression in the dyssynchronous failing heart: D.D. Spragg, et al.; Circulation 108, 929 (2003) Abstract; Full Text Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart: M. Zheng, et al.; Am. J. Physiol. Heart Circ. Physiol. 286, H424 (2004) Abstract; Full Text Autologous stem cell transplantation for myocardial repair: J. Liu, et al.; Am. J. Physiol. Heart Circ. Physiol. 287, H501 (2004) Abstract; Full Text Doxycycline inducible expression of SERCA2a improves calcium handling and reverts cardiac dysfunction in pressure overload-induced cardiac hypertrophy: J. Suarez, et al.; Am. J. Physiol. Heart Circ. Physiol. 287, H2164 (2004) Abstract; Full Text The Na(+)-K(+)-ATPase alpha2-subunit isoform modulates contractility in the perinatal mouse diaphragm: T.L. Radzyukevich, et al.; Am. J. Physiol. Cell Physiol. 287, C1300 (2004) Abstract; Full Text Frequency- and afterload-dependent cardiac modulation in vivo by troponin I with constitutively active protein kinase A phosphorylation sites: E. Takimoto, et al.; Circ. Res. 94, 496 (2004) Abstract; Full Text Alterations in myofilament function contribute to left ventricular dysfunction in pigs early after myocardial infarction: J. van der Velden, et al.; Circ. Res. 95, e85 (2004) Abstract; Full Text Adenylyl cyclase type VI gene transfer reduces phospholamban expression in cardiac myocytes via activating transcription factor 3: M.H. Gao, et al.; J. Biol. Chem. 279, 38797 (2004) Abstract; Full Text Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunction: M. Nakayama, et al.; Am. J. Physiol. Heart Circ. Physiol. 288, H317 (2005) Abstract; Full Text Genetic manipulation of calcium-handling proteins in cardiac myocytes. I. Experimental studies: P. Coutu and J.M. Metzger; Am. J. Physiol. Heart Circ. Physiol. 288, H601 (2005) Abstract; Full Text Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure: B.A. Rothermel, et al.; Physiol. Genomics 23, 18 (2005) Abstract; Full Text
|